InnoPharmax
About
About Us
Organization
Our History
News
News
Technologies
OralPAS®
OralPAS Pro®
MUCR™
R&D
Pipeline
D07001 GemOral
D0191801 Oral Insulin
D0282102 Bendamustine RTD
Products
Anti-infection Agents
Contrast Agents
Oncology Agents
Immunological Agents
Drugs for Rare Diseases
Active Pharmaceutical Ingredient
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
ZH-TW
Investor Relations
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Financial Statements
>
Financial Information
>
Investor Relation
>
home
Financial Statements
(Ticker Symbol: 4172)
All
2017
2016
2015
2014
2013
2012
2017
2017Q3 Financial Statement
2017 Semiannual Financial Statement
2016
2016 Financial Statement
2016 Semiannual Financial Statement
2015
2015 Financial Statement
2015 Semiannual Financial Statement
2014
2014 Financial Statement
2014 Semiannual Financial Statement
2013
2013 Financial Statement
2013 Semiannual Financial Statement
2012
2012 Financial Statement
2012 Semiannual Financial Statement
uGear Design
-
Website Info.
